BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12950164)

  • 1. Structure and dynamics of the lantibiotic mutacin 1140.
    Smith L; Zachariah C; Thirumoorthy R; Rocca J; Novák J; Hillman JD; Edison AS
    Biochemistry; 2003 Sep; 42(35):10372-84. PubMed ID: 12950164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications.
    Perez RH; Zendo T; Sonomoto K
    Microb Cell Fact; 2014 Aug; 13 Suppl 1(Suppl 1):S3. PubMed ID: 25186038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lantibiotic resistance.
    Draper LA; Cotter PD; Hill C; Ross RP
    Microbiol Mol Biol Rev; 2015 Jun; 79(2):171-91. PubMed ID: 25787977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloduracin α binds the peptidoglycan precursor lipid II with 2:1 stoichiometry.
    Oman TJ; Lupoli TJ; Wang TS; Kahne D; Walker S; van der Donk WA
    J Am Chem Soc; 2011 Nov; 133(44):17544-7. PubMed ID: 22003874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering Potential Bacteriocins Against Pseudomonas fragi: a Subtractive Proteomics and Molecular Dynamic Simulation Study for Food Preservation.
    Azhar M; Yousaf M; Maher S; Fatmi MQ
    Appl Biochem Biotechnol; 2024 May; 196(5):2851-2868. PubMed ID: 37103735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lantibiotics as probes for phosphatidylethanolamine.
    Zhao M
    Amino Acids; 2011 Nov; 41(5):1071-9. PubMed ID: 21573677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus.
    Biswas S
    Microbiol Spectr; 2023 Feb; 11(1):e0303022. PubMed ID: 36645288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of analogs of mutacin 1140 in systemic and cutaneous methicillin-resistant
    Ju M; Joseph T; Hansanant N; Geng M; Williams M; Cothrell A; Buhrow AR; Austin F; Smith L
    Front Microbiol; 2022; 13():1067410. PubMed ID: 36590413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant
    Hernández-Aristizábal I; Ocampo-Ibáñez ID
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Chemical Biology Approach to Understanding Molecular Recognition of Lipid II by Nisin(1-12): Synthesis and NMR Ensemble Analysis of Nisin(1-12) and Analogues.
    Dickman R; Danelius E; Mitchell SA; Hansen DF; Erdélyi M; Tabor AB
    Chemistry; 2019 Nov; 25(64):14572-14582. PubMed ID: 31599485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.
    Dickman R; Mitchell SA; Figueiredo AM; Hansen DF; Tabor AB
    J Org Chem; 2019 Sep; 84(18):11493-11512. PubMed ID: 31464129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution NMR studies of antibiotics in cellular membranes.
    Medeiros-Silva J; Jekhmane S; Paioni AL; Gawarecka K; Baldus M; Swiezewska E; Breukink E; Weingarth M
    Nat Commun; 2018 Sep; 9(1):3963. PubMed ID: 30262913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.
    Kers JA; DeFusco AW; Park JH; Xu J; Pulse ME; Weiss WJ; Handfield M
    PLoS One; 2018; 13(6):e0197467. PubMed ID: 29894469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
    Geng M; Smith L
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutacin 1140 Lantibiotic Variants Are Efficacious Against
    Kers JA; Sharp RE; Defusco AW; Park JH; Xu J; Pulse ME; Weiss WJ; Handfield M
    Front Microbiol; 2018; 9():415. PubMed ID: 29615987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Flavoenzymes Catalyze the Post-Translational Generation of 5-Chlorotryptophan and 2-Aminovinyl-Cysteine during NAI-107 Biosynthesis.
    Ortega MA; Cogan DP; Mukherjee S; Garg N; Li B; Thibodeaux GN; Maffioli SI; Donadio S; Sosio M; Escano J; Smith L; Nair SK; van der Donk WA
    ACS Chem Biol; 2017 Feb; 12(2):548-557. PubMed ID: 28032983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.
    Pepperney A; Chikindas ML
    Probiotics Antimicrob Proteins; 2011 Jun; 3(2):68. PubMed ID: 26781572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutations in the lanthipeptide mutacin 1140.
    Chen S; Wilson-Stanford S; Cromwell W; Hillman JD; Guerrero A; Allen CA; Sorg JA; Smith L
    Appl Environ Microbiol; 2013 Jul; 79(13):4015-23. PubMed ID: 23603688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.